TFSA Investors: 3 Reasons to Buy Aphria Stock Today

Cannabis firm Aphria’s (TSX:APHA)(NASDAQ:APHA) stock price rallied to close 9% higher on Monday after W. Andrew Carter, a respected equity analyst at Stifel Financial, upgraded the top marijuana stock from a Hold to a Buy and increased his price target. The analyst’s US$5.90 new price target on APHA shares implied a 26% upside from the company’s previous share price at…

Read More

Cronos (TSX:CRON) Stock: $0 or $30?

Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) is a millionaire-maker stock. The only problem is that it’s also a millionaire-destroyer stock. It all depends on timing. In 2016, shares traded at $0.20. At the start of 2019, they touched $30. In just three years, a $5,000 investment became $750,000. Then the cannabis bear market of 2019 occurred. The industry lost billions of dollars…

Read More

Cannabis Bucks the Coronavirus Growth Downtrend

Uncertain times often lead to surprising success stories. The COVID-19 pandemic crushed entire industries, while pushing cannabis ever closer to full legitimacy. Marijuana businesses depend on innovation – something that is critical in the current environment. As COVID-19 rages, rapid-fire local legislation often disrupts traditional supply lines. Given the patchwork of laws and questionable legality in many jurisdictions, marijuana companies…

Read More

Worried About Bankruptcies? Avoid This Surprising Sector

If you’re worried about bankruptcies, be sure to avoid cinemas, cannabis, and grocery retail. “Whoa, whoa, whoa,” some of you may think. “Grocery retail is in the same bucket as movie theatre and cannabis businesses?” Anyone who has read any of my previous work over the past couple of years knows my thoughts on the long-term future of the mass…

Read More

Should Canadians Buy Aphria (TSX:APHA) Stock Today?

The coronavirus market crash is far from over yet. Non-essential sectors now face even brisker headwinds than previously was the case. This is especially the case in an overcrowded and unsettled space like cannabis. The move by the Ontario government to strike the sector from the “essentials” list was disheartening. But for some pot stocks, it could even have proved…

Read More

Canopy Growth Stock Lagged the TSX by 5.7% in March

Canopy Growth (TSX:WEED)(NYSE:CGC) stock price was already in the throes of despair before the coronavirus crisis. The stock had already fallen dramatically from late 2018/early 2019 highs as the cannabis bubble burst. In March, Canopy Growth stock price continued to underperform the TSX, lagging it by 5.7%. During the month of March, all eyes were on developments related to the…

Read More

Cannabis Sales Jump Amidst Coronavirus Lockdown

Cannabis sales have seen significant growth recently as consumers around the country continue to stockpile supplies to prepare for prolonged self-isolation. This phenomenon isn’t new, of course. Historically, as the economy starts to go down, consumers tend to rely more on vices such as alcohol or, in this case, weed. As dispensaries in many areas are being considered essential businesses,…

Read More

Coronavirus Market Meltdown: Buy Canopy Growth Stock for Defensive Pot Status

Speculations on whether the cannabis industry is a defensive, non-cyclical consumer staple producer with resilient sales that remain strong during economic recessions will settle when financial results for the first calendar quarter of 2020 start creeping in. Until then, should cannabis investors consider industry leader Canopy Growth’s (TSX:WEED)(NYSE:CGC) stock a defensive play during the ongoing coronavirus-induced economic meltdown? Canopy Growth…

Read More

The Cannabis Connection to Coronavirus

That Canadians are stressed shouldn’t come as much of a shock. After all, the COVID-19 crisis has sent stocks plummeting, one in three Canadians worry they won’t make rent or mortgage payments, and thousands of people have lost their jobs. It’s therefore little wonder that some Canadians have turned to cannabis for stress relief. Canadians have flooded online cannabis retail…

Read More

This Pot Stock Is Capitalizing on the Bear Market

Every pot stock has been crushed. The marijuana bear market of 2019 sent cannabis ETFs down by more than 50%. The coronavirus bear market of 2020 has compounded the damage. Pot demand continues to grow. That’s not the issue. In 2019, the problem was commoditization. Tilray sent the industry into a nosedive last summer when it reported a pricing collapse.…

Read More